Chatterjee S et al., 2026-06-17: Expert-derived management algorithm for post-cardiac-surgery vasoplegic shock placing methylene blue among complementary adjuncts for refractory cases, after norepinephrine, vasopressin and angiotensin II.
Adjuncts such as methylene blue, hydroxocobalamin, and corticosteroids are complementary and considered in refractory cases, guided by mechanism and adverse effect profile.
Chatterjee S et al., 2026-06-17: Expert-derived management algorithm for post-cardiac-surgery vasoplegic shock placing methylene blue among complementary adjuncts for refractory cases, after norepinephrine, vasopressin and angiotensin II. C5 (guideline statement). Study type: structured expert review by a 12-clinician panel from 6 institutions (cardiac surgeons, anesthesiologists, intensivists, pharmacists); Baylor College of Medicine affiliation for the first author, USA. No patients enrolled; PubMed and Embase searched. Reported incidence of vasoplegic shock 5-50%. Disclosures: Rakesh C. Arora reports relationships with Edwards Lifesciences, Medtronic, Serb Pharmaceuticals, HLS Therapeutics and others per the record (business ties disclosed neutrally). Ann Thorac Surg 2026;122:909-920. Study type: review.
